Source-quality evidence starts with official databases, peer-reviewed literature, and recognized analytical guidance
There are no clinical trials, and injectable/in-vivo data come from the sister peptide GHK-Cu in animals
Improves Overall Wellness and Health The combination of vitamins and amino acids enhances metabolism and supports general health, including liver function
Monitoring Protocol for Off-Label GHK-Cu Use For clinicians who, after informed consent discussions, proceed with off-label GHK-Cu for wound healing, systematic monitoring is necessary
1 to 3 mL per vial is typical
According to the NICE Clinical Knowledge Summary (CKS) and the British National Formulary (BNF) , the standard treatment for B12 deficiency without neurological symptoms involves: Hydroxocobalamin 1 mg intramuscularly three times weekly for two weeks Followed by maintenance doses of 1 mg every three months For patients with neurological symptoms (such as paraesthesia, numbness, cognitive changes, or gait disturbances), more intensive treatment is required: Hydroxocobalamin 1 mg intramuscularly on alternate days until no further improvement occurs Followed by 1 mg every two months for maintenance Pernicious anaemia , an autoimmune condition where the body cannot produce intrinsic factor, requires lifelong treatment
